Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients
Angelison, L., Almer, S., Eriksson, A., Karling, P., Fagerberg, U., Halfvarson, J., Thörn, M., Björk, J., Hindorf, U., Löfberg, R., Bajor, A., Hjortswang, H., Hammarlund, P., Grip, O., Torp, J., Marsal, J., Hertervig, E.
Published in Alimentary pharmacology & therapeutics (01.02.2017)
Published in Alimentary pharmacology & therapeutics (01.02.2017)
Get full text
Journal Article
P533 Excellent long-term outcome in infliximab treated patients with chronic active ulcerative colitis
Angelison, L., Almer, S., Hindorf, U., Hertervig, E.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
P189 - Is inosine-5′-monophosphate dehydrogenase of importance in thiopurine treated patients who display a “skewed” metabolite profile?
Haglund, S., Taipalensuu, J., Vikingsson, S., Coulthard, S., Peterson, C., Hindorf, U., Danelius, M., Almer, S.
Published in Journal of Crohn's and colitis (01.02.2009)
Published in Journal of Crohn's and colitis (01.02.2009)
Get full text
Journal Article